BELLICUM PHARMACEUTICALS
Bellicum Pharmaceuticals is a clinical stage company developing next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer and chronic infectious diseases. Bellicum's novel approach is to utilize precise knowledge of the signaling pathways that regulate the immune response to target specific factors that can influence the potency and duration of this response.
BELLICUM PHARMACEUTICALS
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2004-07-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.bellicum.com
Total Employee:
101+
Status:
Active
Contact:
(832) 384-1100
Email Addresses:
[email protected]
Total Funding:
289.58 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Xilio Therapeutics
Xilio Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - Bellicum Pharmaceuticals
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Bellicum Pharmaceuticals
RA Capital Management
RA Capital Management investment in Series C - Bellicum Pharmaceuticals
Ridgeback Capital
Ridgeback Capital investment in Series C - Bellicum Pharmaceuticals
Ridgeway Capital Partners
Ridgeway Capital Partners investment in Series C - Bellicum Pharmaceuticals
Sabby Capital
Sabby Capital investment in Series C - Bellicum Pharmaceuticals
Aju IB Investment
Aju IB Investment investment in Series C - Bellicum Pharmaceuticals
Jennison Associates
Jennison Associates investment in Series C - Bellicum Pharmaceuticals
Redmile Group
Redmile Group investment in Series C - Bellicum Pharmaceuticals
Perceptive Advisors
Perceptive Advisors investment in Series C - Bellicum Pharmaceuticals
Official Site Inspections
http://www.bellicum.com Semrush global rank: 4.25 M Semrush visits lastest month: 2.75 K
- Host name: 192-185-225-144.unifiedlayer.com
- IP address: 192.185.225.144
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092